HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note.

Abstract
Detection of DNA fragments in situ using the terminal deoxyribonucleotidyl transferase (TDT)-mediated dUTP-digoxigenin nick end labeling (TUNEL) assay is increasingly applied to investigate active cell death (apoptosis). We studied the specificity of the assay in well-defined models of apoptosis and necrosis as well as in postmortem autolysis in rat liver. During involution of liver hyperplasia, which follows stopping treatment with the hepatomitogens cyproterone acetate (CPA) or nafenopin (NAF), numerous apoptotic hepatocytes could be observed with TUNEL-positive chromatin residues. A similar TUNEL-positive reaction appeared in necrotic hepatocytes after a cytotoxic dose of carbon tetrachloride (CCl4) or N-nitrosomorpholine (NNM). Also, in insufficiently fixed, autolytic livers TUNEL-positive nuclei were observed. Thus, DNA fragmentation is common to different kinds of cell death; its detection in situ should not be considered a specific marker of apoptosis.
AuthorsB Grasl-Kraupp, B Ruttkay-Nedecky, H Koudelka, K Bukowska, W Bursch, R Schulte-Hermann
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 21 Issue 5 Pg. 1465-8 (May 1995) ISSN: 0270-9139 [Print] United States
PMID7737654 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA
  • Carbon Tetrachloride
Topics
  • Animals
  • Apoptosis
  • Autolysis
  • Carbon Tetrachloride (pharmacology)
  • Cell Death
  • DNA (analysis)
  • DNA Damage
  • Female
  • Genetic Techniques
  • Liver (cytology, metabolism, physiology)
  • Male
  • Necrosis
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: